Influence of Adding Empagliflozin to Conventional Anti-diabetic Therapy on Quality of Life Scale for Type 2 Diabetic Patients
To evaluate the efficacy of empagliflozin on the quality of life (QoL) and glycemic index in patients with type 2 diabetes mellitus (T2DM) inadequately controlled with conventional oral anti-diabetic agents (OADs). A pre-post study involved forty T2DM patients who were on a combination of three OADs...
Saved in:
Main Authors: | Hadeel Delman Najim (Author), Mohammed Mahmood Mohammed (Author), Abbas Mahdi Rahmah (Author) |
---|---|
Format: | Book |
Published: |
College of Pharmacy University of Baghdad,
2024-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effects of Metformin &/or Glimepiride on Resistin Level and Related Biochemical Markers in Type 2 Diabetes Mellitus
by: Hadeel Delman Najim, et al.
Published: (2014) -
Combination therapy in type 2 diabetes mellitus: adding empagliflozin to basal insulin
by: Andrew Ahmann
Published: (2015) -
Empagliflozin in the treatment of type 2 diabetes: evidence to date
by: Shubrook JH, et al.
Published: (2015) -
The role of empagliflozin in the management of type 2 diabetes by patient profile
by: Hedrington MS, et al.
Published: (2015) -
Differential pharmacology and clinical utility of empagliflozin in type 2 diabetes
by: Munir KM, et al.
Published: (2016)